SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001079973-24-000276
Filing Date
2024-02-20
Accepted
2024-02-20 16:01:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G shn_13g.htm SC 13G 40849
  Complete submission text file 0001079973-24-000276.txt   42780
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Subject) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-58467 | Film No.: 24653114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301
Business Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301 927(0)779800501
S.H.N. Financial Investments Ltd. (Filed by) CIK: 0001890802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G